share_log

What's Going On With Nasdaq-100 Leveraged ETF TQQQ

What's Going On With Nasdaq-100 Leveraged ETF TQQQ

納斯達克100槓桿ETF TQQQ怎麼回事
Benzinga ·  2023/09/13 11:49

ProShares UltraPro QQQ (NASDAQ:TQQQ) shares are trading higher by 1.9% to $41.30 Wednesday morning. The ETF is trading higher following worse-than-expected U.S. inflation data.

ProShares UltraPro Q 納斯達克股票代碼:TQQQ)股價週三上午上漲1.9%,至41.30美元。在美國通脹數據低於預期之後,該ETF的交易價格走高。

Rising inflation can lead to concerns about the Federal Reserve implementing tighter monetary policy, potentially including interest rate hikes. However, the impact of rising interest rates on TQQQ can be mixed.

通貨膨脹率上升可能導致人們對美聯儲實施更緊縮的貨幣政策(可能包括加息)的擔憂。但是,利率上升對TQQQ的影響可能好壞參半。

Higher rates can increase borrowing costs and potentially reduce profit margins for tech companies, but they can also attract income-seeking investors away from bonds and into high-growth equities, like those in the tech sector.

更高的利率會增加借貸成本,並可能降低科技公司的利潤率,但它們也可以吸引尋求收入的投資者從債券轉向高增長股票,例如科技行業。

For the unitiated, per ProShares, TQQQ seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 (NASDAQ:QQQ) ETF.

根據ProShares的說法,對於聯合企業,TQQQ尋求扣除費用和支出前的每日投資業績,相當於每日表現的三倍(3倍) 納斯達克100 (納斯達克股票代碼:QQQ)等

Inflation Surges Beyond Expectations In August

通貨膨脹飆升超出預期 在八月

The annual CPI inflation rate soared from 3.2% in July to a notable 3.7% in August 2023, surpassing economist expectations of a 3.6% increase.

年消費者價格指數通脹率從7月份的3.2%飆升至2023年8月的3.7%,超過了經濟學家預期的3.6%的增長。

On a monthly basis, the CPI accelerated sharply, rising by 0.6% in August, a stark contrast to the 0.2% increase seen in July, but in line with expectations. This marked the sharpest monthly CPI increase since June 2022...Read More

按月計算,消費者價格指數急劇加速,8月份上漲0.6%,與7月份的0.2%形成鮮明對比,但符合預期。這是自2022年6月以來最大的月度消費者價格指數漲幅...閱讀更多

According to data from Benzinga Pro, TQQQ has a 52-week high of $47.14 and a 52-week low of $16.10.

根據Benzinga Pro的數據,TQQQ創下52周高點爲47.14美元,52周低點爲16.10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論